Expression of miR-101-3p and its target ADAM15 gene in colorectal cancer patients

Purpose: This study aims to evaluate the expression patterns of miR-101-3p and its target ADAM15 in colorectal cancer patients. Materials and Methods: Thirty patients with colorectal cancer had their tumor and corresponding normal tissue samples taken. Following RNA extraction, real-time PCR (qRT-PCR) was used to determine the relative expression of miR-101-3p and its anticipated target gene, ADAM15, using β-actin as a housekeeping gene. The 2^–ΔΔCt technique was used to determine the relative gene expression levels Results: Considering colorectal malignant tissues compared to their surrounding non-cancerous counterparts, miR-101-3p expression was significantly lower. On the other hand, tumor tissues showed noticeably higher levels of ADAM15 mRNA. The expression levels of miR-101-3p and ADAM15 were shown to be significantly inversely correlated (r = -0.6719, p < 0.05). Conclusion: Our results suggest that miR-101-3p potentially regulates the expression of ADAM15, whose upregulation is associated with tumor tissues. The hypothesis that their interaction may play a significant role in the pathogenesis of CRC is supported by the inverse correlation between these two markers. More studies are required, particularly with bigger patient populations. These results highlight the potential of the miR-101-3p/ADAM15 pathway as a useful biomarker for the future diagnosis or treatment of colorectal cancer.